ArticleFrontiers in neurology
Using multimodal imaging to improve the diagnostic accuracy and confidence in distinguishing non-arteritic anterior ischemic optic neuropathy from optic disc drusen.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Optic nerve head elevation (ONHE) is a common diagnostic challenge in the general eye clinic. When caused by optic disc edema (ODE), ONHE may signal a neuro-ophthalmic emergency requiring urgent and invasive evaluation, whereas pseudoedema typically does not. This study evaluated whether multimodal oph¬thalmic imaging improves diagnostic accuracy and confidence in distinguishing nonarteritic anterior ischemic optic neuropathy (NAION), used as a model of true ODE, from optic disc drusen (ODD), a common cause of pseudoedema. Methods: We prospectively collected multimodal ophthalmic images using fundus color, near-infrared reflectance (NIR), fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (OCT) optic nerve head and retinal nerve fiber layer (RNFL) analysis from 98 subjects (149 eyes: 60 NAION, 59 ODD, 30 controls). After a two-hour training session with a neuro-ophthalmologist, two masked medical trainees (a senior medical student and a recent medical gradu¬ate) independently reviewed single-, dual-, or multimodal image sets using a 0-5 confidence-weighted scale to assess for NAION, ODD, and control. Diagnostic accuracy was calculated using a weighted scoring system that penalized uncer¬tainty and misclassification. Confidence levels were categorized as high (defi¬nite), medium (likely), or low (maybe). Results: Among single imaging modalities, NAION diagnostic accuracy was highest with RNFL (83.2%) and color fundus imaging (80.9%), and lowest with FAF (65.4%). Combining color + RNFL improved accu¬racy to 88.1%. For ODD, FAF alone yielded the highest accuracy of 82.3%. The diagnostic accuracy of control images was consistently high across all single modalities (84.2 to 93.8%). Multimodal imaging produced the highest accuracy overall (NAION 93.4%, ODD 90.5%, controls 99.5%). The highest improvement using multimodal imaging was in NAION diagnostic confidence, which improved from 3 to 37% with single modality to 28 to 82% with multimodal imaging. We used mixed ANOVA and chi-square tests to evaluate diagnostic accuracy and grader confidence across modalities. Discussion: Brief training combined with multimodal imaging significantly improved diagnostic accuracy and confidence in differentiating NAION, ODD, and healthy controls. These findings support the potential clinical value of multimodal imaging in urgent-care settings where rapid and reliable evaluation of ONHE is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.